Odisha Health Department Makes Moves to Procure Ivermectin to Treat COVID-19 Patients

Oshida Health Department Makes Moves to Procure Ivermectin to Treat COVID-19 Patients

The state health department here in this eastern Indian state called Odisha strongly recommended procuring 720,000 ivermectin doses for those infected with SARS-CoV-2 currently in home isolation. Despite the World Health Organization (WHO) edict to only use the generic, the U.S. Food and Drug Administration (FDA) approved the drug for clinical trials. India has bucked the trend of the West and has included ivermectin in its national COVID-19 treatment guidelines. What the press is censoring across the board is the dramatic impact the population-wide ivermectin program appears to be having in Uttar Pradesh. The state issued an aggressive population-wide ivermectin home health program that appears to be effective. As reported by TrialSite, Ivermectin was included in the national COVID-19 treatment guidelines by April 22, 2021, and shortly after, Uttar Pradesh instituted a population-wide Ivermectin-based program. What’s the impact? The apex of new daily cases at 33,531 occurred on April 26. Since then, there’s been a steady decline, and while TrialSite cannot prove that ivermectin is the direct cause of this decline, it’s certainly the case that the decline corresponds with the mass...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee